Comparison of the efficacy and survival analysis of neoadjuvant chemotherapy for Her-2-positive breast cancer

PURPOSE: The objective of this research was to compare the short- and long-term efficacy of the following four neoadjuvant chemotherapy (NAC) regimens: docetaxel/carboplatin/trastuzumab (TCH), docetaxel/epirubicin/cyclophosphamide (TEC), Xeloda/epirubicin/cyclophosphamide followed by Xeloda/docetaxe...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Si, Wei, Wei, Jiang, Yi, Li, Qiuyun, Huang, Qinghua, Yang, Huawei, Liu, Jianlun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6157574/
https://www.ncbi.nlm.nih.gov/pubmed/30275685
http://dx.doi.org/10.2147/DDDT.S171534

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6157574/
https://www.ncbi.nlm.nih.gov/pubmed/30275685
http://dx.doi.org/10.2147/DDDT.S171534

Ejemplares similares